Osteoarthritis Clinical Trials in Orlando

View 33 new treatments for Osteoarthritis in Orlando, FL. Every day, Power helps hundreds of Osteoarthritis patients connect with leading medical research.

TG-C for Osteoarthritis of the Knee

Kolon TissueGene Clinic, Viera + 4 more

This trial tests TG-C, an injection into the knee, for patients with moderate to severe osteoarthritis. It aims to reduce pain and improve knee function by potentially modifying the disease. TG-C has shown promise in previous studies for managing knee osteoarthritis.Show More

Verified

Recruiting
Phase 3
Est. 5 - 8 Weeks
Moon Jong Noh, PhD
Study Chair

TG-C for Knee Osteoarthritis

Kolon TissueGene Clinic, DeLand + 2 more

This trial tests TG-C, an injection into the knee, for people with moderate to severe knee osteoarthritis. It aims to see if TG-C can reduce pain and improve knee function by potentially altering the disease. The study will monitor patients for safety and effectiveness over time. TG-C has been previously studied for its potential to improve knee joint function and reduce pain in osteoarthritis patients.Show More
Waitlist
Phase 3
Est. 3 - 6 Weeks
David W Romness, MD
Principal Investigator

RTX-GRT7039 Injections for Knee Osteoarthritis

Grünenthal Clinic, Port Orange + 1 more

This trial uses knee injections called RTX-GRT7039 for patients with knee osteoarthritis who still have pain despite usual treatments. The injections aim to reduce knee pain, possibly by affecting pain pathways or inflammation.Show More
Waitlist

No Placebo Trial

Phase 3
Est. 3 - 12 Weeks
Unregistered Study Lead
Research Team

RTX-GRT7039 Injection for Osteoarthritis

Grünenthal Clinic, Orlando + 4 more

This trial tests a special injection called RTX-GRT7039 to help reduce knee pain in people with osteoarthritis who still have pain despite usual treatments. The injection works by blocking pain signals from the knee.Show More
Waitlist
Phase 3
Est. 6 - 12 Weeks
Unregistered Study Lead
Research Team

Retatrutide for Obesity

Eli Lilly Clinic, Port Orange + 3 more

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits.Show More
Waitlist
Phase 3
Est. 4 - 6 Weeks
Call 1-877-CTLILLY (1-877-285-4559 or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST)
Study Director

A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES)

Biosplice Clinic, Winter Park + 8 more

This trial tests a knee injection called lorecivivint for people with severe knee osteoarthritis. The injection aims to reduce pain and improve movement by targeting the painful knee directly. Lorecivivint (LOR) is being tested for its potential to treat osteoarthritis.Show More
Recruiting
Phase 3
Est. 5 - 8 Weeks
Yusuf Yazici, M.D.
Study Director

Pentosan Polysulfate Sodium Injections for Osteoarthritis

Paradigm Biopharmaceuticals Clinic, Port Orange + 3 more

This trial tests if a new treatment can reduce pain and improve function in people with knee osteoarthritis. The medication aims to reduce inflammation and help repair knee joint damage.Show More
Recruiting
Phase 2 & 3
Est. 6 - 12 Weeks
Thomas Schnitzer
Principal Investigator

QUC398 for Knee Osteoarthritis

Novartis Clinic, Maitland + 1 more

This trial is testing a new treatment called QUC398 to see if it can help people with knee osteoarthritis. The study will check if QUC398 can reduce knee pain and protect the cartilage in the knee. Researchers also want to make sure it is safe and well-tolerated.Show More
Recruiting
Phase 2
Est. 4 - 6 Weeks
Novartis Pharmaceuticals
Study Director

DFV890 for Knee Osteoarthritis

Novartis Clinic, Winter Park + 1 more

This trial is testing a new medication called DFV890 to see if it can help people with painful knee osteoarthritis. The study will check if the medication can reduce knee pain and improve how well the knee works. Participants will be monitored for safety and how well they tolerate the medication.Show More
Recruiting
Phase 2
Est. 4 - 6 Weeks
Unregistered Study Lead
Research Team

RHH646 for Knee Osteoarthritis

Novartis Clinic, Winter Park + 2 more

This trial is testing RHH646, a treatment aimed at repairing knee cartilage. It targets people with knee osteoarthritis, a condition where knee cartilage wears down. The treatment helps rebuild this cartilage, potentially reducing pain and improving movement.Show More
Waitlist
Phase 2
Est. 6 - 12 Weeks
Unregistered Study Lead
Research Team
Page 1 of 2

Frequently Asked Questions

How much do osteoarthritis clinical trials pay?

Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.

Do I need to be insured to participate in a medical study?

Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

How do osteoarthritis clinical trials work?

After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across osteoarthritis trials in Orlando, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for osteoarthritis patients is 6 Months.

What does the "phase" of a clinical trial mean?

The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.